ImmunityBio Faces Securities Fraud Lawsuit Over Anktivas Marketing Claims
Kirby McInerney LLP filed securities fraud lawsuit against ImmunityBio over allegedly misleading Anktivas marketing. FDA warning letter triggered 21.2% stock decline.
KDIBRXSMCIsecurities fraudclass action lawsuit
